Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss injections such as Mounjaro (tirzepatide) and Wegovy (semaglutide) are available in the UK through private prescription, and for most people the cost is an ongoing monthly commitment rather than a one-off expense. Understanding how finance arrangements interact with a prescription-only medicine helps you plan realistically before you start. These are prescription-only medicines; a clinician must assess your suitability before any treatment can be dispensed, and that assessment shapes not just whether you qualify medically but how much you will spend over time.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before looking at any payment arrangement, it helps to be clear about what the cost of private weight loss injections covers. Legitimate providers charge for a package: the clinical consultation, the prescriber's review, the medicine itself, and delivery. Some clinics list these separately; others roll them into a single monthly figure. Either way, the prescription is not optional, Mounjaro and Wegovy are prescription-only weight loss injections under UK law, which means a qualified prescriber must assess you before treatment is issued, every single time, including repeat orders.
Why does this matter for finance? Because any arrangement that appears to offer the medicine without that clinical step attached is not a legitimate deal, it is a red flag. The MHRA has publicly warned that fake weight-loss pens have been sold online, and large seizures of counterfeit stock have been made across the UK. A genuine treatment price always reflects the clinical infrastructure behind it.
Once you know that, comparing costs across providers becomes more meaningful. The full cost picture for weight loss injections covers what different price points typically include or quietly leave out.
Some private weight-loss clinics partner with third-party lenders) Klarna, Payl8r, Clearpay and similar, to let patients spread treatment costs over several months. These are standard regulated consumer credit products, and the usual rules apply: interest may be charged after an initial period, missed payments affect your credit file, and the total repaid can exceed the upfront price.
A few practical points worth thinking through. Weight loss injection treatment is ongoing, typically month to month, so a finance arrangement taken out for a single pen does not automatically cover subsequent orders. You would need to re-apply, or use a standing arrangement, for each new prescription cycle. This is different from, say, financing a one-off piece of equipment. The month-to-month nature of clinically supervised treatment means the smarter financial question is often: what is the all-in monthly cost including consultation, prescription, and delivery, and can I sustain that over six to twelve months?
If you are considering finance for weight loss injections, check whether the provider's credit partner is authorised by the Financial Conduct Authority (FCA) before agreeing to terms, and it is also worth reading up on whether weight loss injections insurance could form part of your broader financial planning for treatment. That is the consumer credit equivalent of checking a pharmacy's GPhC registration.
Before committing to any private finance arrangement, it is worth checking whether you might qualify for NHS treatment. The NHS is rolling out Mounjaro in primary care in phased stages, guided by NICE's clinical guidance on weight loss injections. As of summer 2026, the first cohort requires a BMI of 40 or above alongside four or more specific weight-related conditions. A second cohort covering BMI 35 to 39.9 with four or more of those conditions opened in June 2026. Thresholds are set 2.5 kg/m² lower for some ethnic backgrounds under UK guidance. Wegovy on the NHS remains linked to specialist weight management services, where waiting lists can be considerable.
For people who do not yet meet these criteria, or who prefer not to wait, private treatment through a regulated weight management service is the realistic route. Understanding the NHS picture is not defeatist, it helps you make a genuinely informed financial decision rather than an impulsive one driven by frustration with the system.
When the internet is full of competing price claims, it can feel like finding the cheapest listing is the goal. For a prescription-only medicine, that is the wrong test. The right questions are: is the pharmacy GPhC-registered, is every order reviewed by a real clinician, is the supply sourced through the licensed UK chain, and is aftercare available when you need it?
At nume, a named prescriber (not a decision algorithm) reads every consultation the same day. Your order, once approved, is dispatched before the end of the working day and arrives the next working day via DPD in plain, unbranded packaging. The tracking notification appears on your phone before you have thought about it. That is what a single transparent price buys: consultation, clinical review, the medicine, and delivery, with no subscription tied around it and no separate invoice for aftercare. We are not the cheapest option available. That is a deliberate position, not an oversight.
If you have questions about how other health conditions or medicines might interact with treatment, our frequently asked questions cover a wide range of clinical and practical topics. For example, whether weight loss injections can be taken alongside levothyroxine is one of the questions our prescribers field regularly, and if you are still weighing up your options you can read about the three main weight loss injections currently available in the UK to understand how they compare. Suitability is always assessed individually.
To explore whether treatment is right for you, speak to our prescribers through a free consultation. There is no obligation, and the clinical review is thorough regardless of whether you proceed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.